The Motley Fool

3 companies to profit from a lower Australian dollar

The Australian dollar has experienced a huge fall in recent times, dropping to US 87c and many economists have forecast it to fall even lower. If you believe the Australian dollar has further to fall, one of the best ways to profit is by purchasing Australian listed companies with significant offshore earnings.

When looking at quality, global Australian companies that earn the majority of their revenue overseas, it’s hard to go past the healthcare sector. Australia has some global leaders in the healthcare sector, including CSL Limited (ASX:CSL), Cochlear Limited (ASX:COH) and ResMed Inc. (CHESS) (ASX:RMD). These companies benefit from a falling dollar once their overseas earnings are converted back into Australian dollars.

CSL earns the majority of its revenue in North America and Europe (approximately 72%) and is one the largest blood plasma producers globally. The share price of CSL has increased by 700% over the past decade, and the shares still look cheap.

Cochlear earns approximately 40% of revenue in North America and 45% in the EMEA region. Although the shares currently look a little expensive, the company is set to benefit over the longer term from growing demand from emerging markets, and increasing government healthcare spends in the developed world.

ResMed is a leader in the treatment of sleep apnea and the potential addressable market for ResMed is huge. Furthermore, ResMed derives the majority of its revenue in the United States and will benefit from an increasing U.S. dollar.

By investing in these companies, Foolish investors can gain through exposure to the growing U.S. economy and falling Australian dollar without taking on direct exchange rate risk.

While these healthcare companies are all great long-term investments, the company mentioned below is still undiscovered and set for huge growth.

The full scoop on our #1 ASX pick – yours FREE

It's not too late! The Motley Fool has issued a firm "BUY" rating on this small but ultra promising ASX company… and you can get the name and code FREE right now. Click here for your free copy of "The Motley Fool's Top Stock for 2014."

Motley Fool contributor Bradley Murphy owns shares in CSL, Cochlear and ResMed mentioned in this article. 

NEW. Five Cheap and Good Stocks to Buy in 2019…

Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.

One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield…

Plus 3 more cheap bets that could position you to profit over the next 12 months!

See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.